AI assistant
EBOS GROUP LIMITED — Director's Dealing 2017
Sep 22, 2017
64813_rns_2017-09-22_0319fa6a-3a28-4519-96d7-4452e7e69107.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [105 x 14] intentionally omitted <==
==> picture [105 x 15] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 22-Sep-17 | |
| Date of last disclosure: | 27-Sep-16 | |
| Director or senior manager giving disclosure | ||
| Full name(s): | Brett Barons | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | Executive General Manager,Pharmacy |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- |
Summary of acquisition or disposal of relevant interest (excluding specified derivatives Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- |
) |
|---|---|---|
| Class ofaffected quotedfinancialproducts: | Ordinaryshares in EBOS GroupLimited | |
| Nature of the affected relevant interest(s): | Issue of shares pursuant to a long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2017 to 30 June 2020. The executive cannot deal in the shares unless and until those shares vest. |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | N/A | |
| Number held in class after acquisition or disposal: | 55,000 ordinaryshares | |
| Current registered holder(s): | N/A | |
| Registeredholder(s) once transfers areregistered: | Brett Barons | |
| Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab | le) | |
| Type of affected derivative: | N/A | |
| Class of underlyingfinancialproducts: | N/A | |
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): |
N/A | |
| A statement as to whether the derivative is cash settled orphysicallysettled: | N/A | |
| Maturitydate of the derivative(if any): | N/A | |
| Expirydate of the derivative(if any): | N/A | |
| Theprice specified in the terms of the derivative(if any): | N/A | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financialproducts: |
N/A | |
| _For that derivative,- _ | ||
| Parties to the derivative: | N/A | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative: |
N/A | |
| Details of transactions giving rise to acquisition or disposal | ||
| Total number of transactions to which notice relates: | 1 | |
| 22-Sep-17 |
Nature of transaction:
Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration:
Number of financial products to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) — include the following details
Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period:
Date of the prior written clearance (if any):
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products: Nature of relevant interest:
For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
Issue of shares pursuant to a long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2017 to 30 June 2020. The executive cannot deal in the shares unless and until those shares vest. N/A $954,607.50 55,000 ordinary shares No N/A N/A Ordinary shares Registered holder - 2016 long term incentive plan 55,000 ordinary shares Brett Barons N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:
or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:
==> picture [80 x 18] intentionally omitted <==
22-Sep-17 Janelle Cain, General Counsel, EBOS Group Limited
==> picture [105 x 14] intentionally omitted <==
==> picture [105 x 15] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 22-Sep-17 | |
| Date of last disclosure: | 27-Sep-16 | |
| Director or senior manager giving disclosure | ||
| Full name(s): | Michael Broome | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | Group General Manager, HCL & Symbion Contract Logistics |
|
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- |
) | |
| Class ofaffected quotedfinancialproducts: | Ordinaryshares in EBOS GroupLimited | |
| Nature of the affected relevant interest(s): | Issue of shares pursuant to a long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2017 to 30 June 2020. The executive cannot deal in the shares unless and until those shares vest. |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | N/A | |
| Number held in class after acquisition or disposal: | 40,000 ordinaryshares | |
| Current registered holder(s): | N/A | |
| Registeredholder(s) once transfers areregistered: | Michael Broome | |
| Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab | le) | |
| Type of affected derivative: | N/A | |
| Class of underlyingfinancialproducts: | N/A | |
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): |
N/A | |
| A statement as to whether the derivative is cash settled orphysicallysettled: | N/A | |
| Maturitydate of the derivative(if any): | N/A | |
| Expirydate of the derivative(if any): | N/A | |
| Theprice specified in the terms of the derivative(if any): | N/A | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financialproducts: |
N/A | |
| _For that derivative,- _ | ||
| Parties to the derivative: | N/A | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative: |
N/A | |
| Details of transactions giving rise to acquisition or disposal | ||
| Total number of transactions to which notice relates: | 1 | |
| 22-Sep-17 |
Nature of transaction:
Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration:
Number of financial products to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) — include the following details
Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products: Nature of relevant interest:
For that relevant interest,-
Number held in class: Current registered holder(s): For a derivative relevant interest,- Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):
A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
Issue of shares pursuant to a long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2017 to 30 June 2020. The executive cannot deal in the shares unless and until those shares vest. N/A $694,260.00 40,000 ordinary shares No N/A N/A Ordinary shares 1. Registered holder 2. Registered holder - 2016 long term incentive plan 1. 1714 ordinary shares 2. 40,000 ordinary shares 1. Michael Wynston Broome 2. Michael Broome N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer: Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature: Name and title of authorised person:
==> picture [80 x 18] intentionally omitted <==
22-Sep-17 Janelle Cain, General Counsel, EBOS Group Limited
==> picture [105 x 14] intentionally omitted <==
==> picture [105 x 15] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 22-Sep-17 | |
| Date of last disclosure: | 27-Sep-16 | |
| Director or senior manager giving disclosure | ||
| Full name(s): | Simon Bunde | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | General Manager, Group Operations & Strategy |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) | Summary of acquisition or disposal of relevant interest (excluding specified derivatives) | Summary of acquisition or disposal of relevant interest (excluding specified derivatives) | |
|---|---|---|---|
| Class ofaffected quotedfinancialproducts: | Ordinaryshares in EBOS GroupLimited | ||
| Nature of the affected relevant interest(s): | |||
| Issue of shares pursuant to a long term | |||
| incentive plan. While the shares are issued | |||
| and held in the executive's name the shares | |||
| will not vest unless and until performance | |||
| conditions are met. The performance | |||
| conditions will be tested after the end of the | |||
| performance period, being 1 July 2017 to 30 | |||
| June 2020. The executive cannot deal in the | |||
| shares unless and until those shares vest. | |||
| For that relevant interest- | |||
| Number held in class before acquisition or disposal: | N/A | ||
| Number held in class after acquisition or disposal: | 35,000 ordinaryshares | ||
| Current registered holder(s): | N/A | ||
| Registeredholder(s) once transfers areregistered: | Simon Bunde |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives | Summary of acquisition or disposal of relevant interest (excluding specified derivatives | ) |
|---|---|---|
| Class ofaffected quotedfinancialproducts: | Ordinaryshares in EBOS GroupLimited | |
| Nature of the affected relevant interest(s): | Issue of shares pursuant to a long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2017 to 30 June 2020. The executive cannot deal in the shares unless and until those shares vest. |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | N/A | |
| Number held in class after acquisition or disposal: | 35,000 ordinaryshares | |
| Current registered holder(s): | N/A | |
| Registeredholder(s) once transfers areregistered: | Simon Bunde | |
| Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab | le) | |
| Type of affected derivative: | N/A | |
| Class of underlyingfinancialproducts: | N/A | |
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): |
N/A | |
| A statement as to whether the derivative is cash settled orphysicallysettled: | N/A | |
| Maturitydate of the derivative(if any): | N/A | |
| Expirydate of the derivative(if any): | N/A | |
| Theprice specified in the terms of the derivative(if any): | N/A | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financialproducts: |
N/A | |
| _For that derivative,- _ | ||
| Parties to the derivative: | N/A | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative: |
N/A | |
| Details of transactions giving rise to acquisition or disposal | ||
| Total number of transactions to which notice relates: | 1 | |
| 22-Sep-17 |
Nature of transaction:
Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration:
Number of financial products to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) — include the following details
Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period:
Date of the prior written clearance (if any):
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products: Nature of relevant interest:
For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):
A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
Issue of shares pursuant to a long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2017 to 30 June 2020. The executive cannot deal in the shares unless and until those shares vest. N/A $607,477.50 35,000 ordinary shares No N/A N/A Ordinary shares Registered holder - 2016 long term incentive plan 35,000 ordinary shares Simon Bunde N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:
or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:
==> picture [80 x 18] intentionally omitted <==
22-Sep-17 Janelle Cain, General Counsel, EBOS Group Limited
==> picture [105 x 14] intentionally omitted <==
==> picture [105 x 15] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 22-Sep-17 | |
| Date of last disclosure: | 27-Sep-16 | |
| Director or senior manager giving disclosure | ||
| Full name(s): | John Cullity | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | Chief Financial Officer |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- |
Summary of acquisition or disposal of relevant interest (excluding specified derivatives Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- |
) |
|---|---|---|
| Class ofaffected quotedfinancialproducts: | Ordinaryshares in EBOS GroupLimited | |
| Nature of the affected relevant interest(s): | Issue of shares pursuant to a long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2017 to 30 June 2020. The executive cannot deal in the shares unless and until those shares vest. |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | N/A | |
| Number held in class after acquisition or disposal: | 110,000 ordinaryshares | |
| Current registered holder(s): | N/A | |
| Registeredholder(s) once transfers areregistered: | John Cullity | |
| Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab | le) | |
| Type of affected derivative: | N/A | |
| Class of underlyingfinancialproducts: | N/A | |
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): |
N/A | |
| A statement as to whether the derivative is cash settled orphysicallysettled: | N/A | |
| Maturitydate of the derivative(if any): | N/A | |
| Expirydate of the derivative(if any): | N/A | |
| Theprice specified in the terms of the derivative(if any): | N/A | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financialproducts: |
N/A | |
| _For that derivative,- _ | ||
| Parties to the derivative: | N/A | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative: |
N/A | |
| Details of transactions giving rise to acquisition or disposal | ||
| Total number of transactions to which notice relates: | 1 | |
| 22-Sep-17 |
Nature of transaction:
Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration:
Number of financial products to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) — include the following details
Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period:
Date of the prior written clearance (if any):
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
Issue of shares pursuant to a long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2017 to 30 June 2020. The executive cannot deal in the shares unless and until those shares vest. N/A $1,909,215.00 110,000 ordinary shares No N/A N/A Ordinary shares Registered holder - 2016 long term incentive plan 95,000 ordinary shares John Cullity N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:
or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:
==> picture [80 x 18] intentionally omitted <==
22-Sep-17 Janelle Cain, General Counsel, EBOS Group Limited
==> picture [105 x 14] intentionally omitted <==
==> picture [105 x 15] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 22-Sep-17 | |
| Date of last disclosure: | 27-Sep-16 | |
| Director or senior manager giving disclosure | ||
| Full name(s): | Patrick Davies | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | Chief Executive Officer |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- |
Summary of acquisition or disposal of relevant interest (excluding specified derivatives Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- |
) |
|---|---|---|
| Class ofaffected quotedfinancialproducts: | Ordinaryshares in EBOS GroupLimited | |
| Nature of the affected relevant interest(s): | Issue of shares pursuant to a long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2017 to 30 June 2020. The executive cannot deal in the shares unless and until those shares vest. |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | Nil | |
| Number held in class after acquisition or disposal: | 210,000 ordinaryshares | |
| Current registered holder(s): | N/A | |
| Registeredholder(s) once transfers areregistered: | Patrick Davies | |
| le) | ||
| Type of affected derivative: | N/A | |
| Class of underlyingfinancialproducts: | N/A | |
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): |
N/A | |
| A statement as to whether the derivative is cash settled orphysicallysettled: | N/A | |
| Maturitydate of the derivative(if any): | N/A | |
| Expirydate of the derivative(if any): | N/A | |
| Theprice specified in the terms of the derivative(if any): | N/A | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financialproducts: |
N/A | |
| _For that derivative,- _ | ||
| Parties to the derivative: | N/A | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative: |
N/A | |
| Details of transactions giving rise to acquisition or disposal | ||
| Total number of transactions to which notice relates: | 1 | |
| 22-Sep-17 |
Nature of transaction:
Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration:
Number of financial products to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) — include the following details
Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):
Summary of other relevant interests after acquisition or disposal: Class of quoted financial products: Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s): For a derivative relevant interest,- Type of derivative: Details of derivative,- The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):
A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
Issue of shares pursuant to a long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2017 to 30 June 2020. The executive cannot deal in the shares unless and until those shares vest. N/A $3,644,865.00 210,000 ordinary shares No N/A N/A Ordinary shares 1. Beneficial interest 2. Registered holder - 2016 long term incentive plan 3. Direct, non-beneficial interest 1. 31,093 ordinary shares 2. 210,000 ordinary shares 3. 71,592 ordinary shares 1. Austral 5065 Pty Ltd as trustee for the D5 Family Trust 2. Patrick Davies 3. Mark Brendon Waller & Patrick Donald Davies as trustees of the EBOS Staff Share Plan N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or
Signature of person authorised to sign on behalf of director or officer: Date of signature: 22-Sep-17 Janelle Cain, General Counsel, EBOS Group Name and title of authorised person: Limited
==> picture [105 x 14] intentionally omitted <==
==> picture [105 x 15] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 22-Sep-17 | |
| Date of last disclosure: | 15-Nov-16 | |
| Director or senior manager giving disclosure | ||
| Full name(s): | Sean Duggan | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | Chief Executive Officer,Animal Care |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- |
Summary of acquisition or disposal of relevant interest (excluding specified derivatives Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- |
) |
|---|---|---|
| Class ofaffected quotedfinancialproducts: | Ordinaryshares in EBOS GroupLimited | |
| Nature of the affected relevant interest(s): | Issue of shares pursuant to a long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2017 to 30 June 2020. The executive cannot deal in the shares unless and until those shares vest. |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | N/A | |
| Number held in class after acquisition or disposal: | 50,000 ordinaryshares | |
| Current registered holder(s): | N/A | |
| Registeredholder(s) once transfers areregistered: | Sean Duggan | |
| Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab | le) | |
| Type of affected derivative: | N/A | |
| Class of underlyingfinancialproducts: | N/A | |
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): |
N/A | |
| A statement as to whether the derivative is cash settled orphysicallysettled: | N/A | |
| Maturitydate of the derivative(if any): | N/A | |
| Expirydate of the derivative(if any): | N/A | |
| Theprice specified in the terms of the derivative(if any): | N/A | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financialproducts: |
N/A | |
| _For that derivative,- _ | ||
| Parties to the derivative: | N/A | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative: |
N/A | |
| Details of transactions giving rise to acquisition or disposal | ||
| Total number of transactions to which notice relates: | 1 | |
| 22-Sep-17 |
Nature of transaction:
Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration:
Number of financial products to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) — include the following details
Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products: Nature of relevant interest:
For that relevant interest,-
Number held in class: Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
Issue of shares pursuant to a long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2017 to 30 June 2020. The executive cannot deal in the shares unless and until those shares vest. N/A $867,825.00 50,000 ordinary shares No N/A N/A Ordinary shares 1. Registered holder 2. Registered holder - 2016 long term incentive plan 1. 306 shares 2. 45,000 ordinary shares Sean Duggan N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:
or Date of signature: Name and title of authorised person:
Signature of person authorised to sign on behalf of director or officer:
==> picture [80 x 18] intentionally omitted <==
22-Sep-17 Janelle Cain, General Counsel, EBOS Group Limited
==> picture [105 x 14] intentionally omitted <==
==> picture [105 x 15] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 22-Sep-17 | |
| Date of last disclosure: | 27-Sep-16 | |
| Director or senior manager giving disclosure | ||
| Full name(s): | David Lewis | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | General Manager,Onelink Australia |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- |
Summary of acquisition or disposal of relevant interest (excluding specified derivatives Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- |
) |
|---|---|---|
| Class ofaffected quotedfinancialproducts: | Ordinaryshares in EBOS GroupLimited | |
| Nature of the affected relevant interest(s): | Issue of shares pursuant to a long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2017 to 30 June 2020. The executive cannot deal in the shares unless and until those shares vest. |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | N/A | |
| Number held in class after acquisition or disposal: | 35,000 ordinaryshares | |
| Current registered holder(s): | N/A | |
| Registeredholder(s) once transfers areregistered: | David Lewis | |
| Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab | le) | |
| Type of affected derivative: | N/A | |
| Class of underlyingfinancialproducts: | N/A | |
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): |
N/A | |
| A statement as to whether the derivative is cash settled orphysicallysettled: | N/A | |
| Maturitydate of the derivative(if any): | N/A | |
| Expirydate of the derivative(if any): | N/A | |
| Theprice specified in the terms of the derivative(if any): | N/A | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financialproducts: |
N/A | |
| _For that derivative,- _ | ||
| Parties to the derivative: | N/A | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative: |
N/A | |
| Details of transactions giving rise to acquisition or disposal | ||
| Total number of transactions to which notice relates: | 1 | |
| 22-Sep-17 |
Nature of transaction:
Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration:
Number of financial products to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) — include the following details
Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period:
Date of the prior written clearance (if any):
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products: Nature of relevant interest:
For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
Issue of shares pursuant to a long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2017 to 30 June 2020. The executive cannot deal in the shares unless and until those shares vest. N/A $607,477.50 35,000 ordinary shares No N/A N/A Ordinary shares Registered holder - 2016 long term incentive plan 35,000 ordinary shares David Lewis N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:
or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:
==> picture [80 x 18] intentionally omitted <==
22-Sep-17 Janelle Cain, General Counsel, EBOS Group Limited
==> picture [105 x 14] intentionally omitted <==
==> picture [105 x 15] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 22-Sep-17 | |
| Date of last disclosure: | 27-Sep-16 | |
| Director or senior manager giving disclosure | ||
| Full name(s): | Stuart Spencer | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | Executive General Manager, Institutional Healthcare |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- |
Summary of acquisition or disposal of relevant interest (excluding specified derivatives Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- |
) |
|---|---|---|
| Class ofaffected quotedfinancialproducts: | Ordinaryshares in EBOS GroupLimited | |
| Nature of the affected relevant interest(s): | Issue of shares pursuant to a long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2017 to 30 June 2020. The executive cannot deal in the shares unless and until those shares vest. |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | N/A | |
| Number held in class after acquisition or disposal: | 50,000 ordinaryshares | |
| Current registered holder(s): | N/A | |
| Registeredholder(s) once transfers areregistered: | Stuart Spencer | |
| Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab | le) | |
| Type of affected derivative: | N/A | |
| Class of underlyingfinancialproducts: | N/A | |
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): |
N/A | |
| A statement as to whether the derivative is cash settled orphysicallysettled: | N/A | |
| Maturitydate of the derivative(if any): | N/A | |
| Expirydate of the derivative(if any): | N/A | |
| Theprice specified in the terms of the derivative(if any): | N/A | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financialproducts: |
N/A | |
| _For that derivative,- _ | ||
| Parties to the derivative: | N/A | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative: |
N/A | |
| Details of transactions giving rise to acquisition or disposal | ||
| Total number of transactions to which notice relates: | 1 | |
| 22-Sep-17 |
Nature of transaction:
Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration:
Number of financial products to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) — include the following details
Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period:
Date of the prior written clearance (if any):
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products: Nature of relevant interest:
For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
Issue of shares pursuant to a long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2017 to 30 June 2020. The executive cannot deal in the shares unless and until those shares vest. N/A $867,825.00 50,000 ordinary shares No N/A N/A Ordinary shares Registered holder - 2016 long term incentive plan 45,000 ordinary shares Stuart Spencer N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:
or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:
==> picture [80 x 18] intentionally omitted <==
22-Sep-17
Janelle Cain, General Counsel, EBOS Group Limited
==> picture [105 x 14] intentionally omitted <==
==> picture [105 x 15] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and Name of listed issuer: EBOS Group Limited Date this disclosure made: 22-Sep-17 Date of last disclosure: 27-Sep-16 Director or senior manager givingector or senior manager givingr or senior manager givingor senior manager givingr senior manager givingsenior manager givingnior manager givingor manager givingr manager givinganager givingnager givingager givingr givinggivingivingg disclosureisclosuresclosurelosureosureree Full name(s):(s):s):):: Andrew Vidler Name of listed issuer: EBOS Group Limited Name of related body corporate (if applicable): N/A Position held in listed issuer: Executive General Manager, Endeavour Consumer Health
Director or senior manager givingector or senior manager givingr or senior manager givingor senior manager givingr senior manager givingsenior manager givingnior manager givingor manager givingr manager givinganager givingnager givingager givingr givinggivingivingg disclosureisclosuresclosurelosureosureree Full name(s):(s):s):):: Name of listed issuer: Name of related body corporate (if applicable): Position held in listed issuer:
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- |
Summary of acquisition or disposal of relevant interest (excluding specified derivatives Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- |
) |
|---|---|---|
| Class ofaffected quotedfinancialproducts: | Ordinaryshares in EBOS GroupLimited | |
| Nature of the affected relevant interest(s): | Issue of shares pursuant to a long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2017 to 30 June 2020. The executive cannot deal in the shares unless and until those shares vest. |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | N/A | |
| Number held in class after acquisition or disposal: | 40,000 ordinaryshares | |
| Current registered holder(s): | N/A | |
| Registeredholder(s) once transfers areregistered: | Andrew Vidler | |
| Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab | le) | |
| Type of affected derivative: | N/A | |
| Class of underlyingfinancialproducts: | N/A | |
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): |
N/A | |
| A statement as to whether the derivative is cash settled orphysicallysettled: | N/A | |
| Maturitydate of the derivative(if any): | N/A | |
| Expirydate of the derivative(if any): | N/A | |
| Theprice specified in the terms of the derivative(if any): | N/A | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financialproducts: |
N/A | |
| _For that derivative,- _ | ||
| Parties to the derivative: | N/A | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative: |
N/A | |
| Details of transactions giving rise to acquisition or disposal | ||
| Total number of transactions to which notice relates: | 1 | |
| 22-Sep-17 |
Nature of transaction:
Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration:
Number of financial products to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) — include the following details
Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period:
Date of the prior written clearance (if any):
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products: Nature of relevant interest:
For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):
A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
Issue of shares pursuant to a long term incentive plan. While the shares are issued and held in the executive's name the shares will not vest unless and until performance conditions are met. The performance conditions will be tested after the end of the performance period, being 1 July 2017 to 30 June 2020. The executive cannot deal in the shares unless and until those shares vest. N/A $694,260.00 40,000 ordinary shares No N/A N/A Ordinary shares Registered holder - 2016 long term incentive plan 40,000 ordinary shares Andrew Vidler N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:
or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:
==> picture [80 x 18] intentionally omitted <==
22-Sep-17 Janelle Cain, General Counsel, EBOS Group Limited